[RVMD] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[RVMD] Revolution Medicines, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -3.54%
YoY- -2.02%
Quarter Report
RVMD's Result
RVMD's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 742 0 3,824 7,014 15,330 3,356 9,116 -81.13%
PBT -161,194 -112,301 -98,298 -68,098 -56,630 -73,626 -61,222 90.33%
Tax 343 3,867 -1,773 -9,592 -123 -297 -867 -
NP -161,537 -108,434 -98,298 -58,506 -56,507 -73,329 -60,355 92.42%
Tax Rate - - - - - - - -
Total Cost 162,279 108,434 102,122 65,520 71,837 76,685 69,471 75.77%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -21,770.49 0.00 -2,570.55 -834.13 -368.60 -2,185.01 -662.08 919.86%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.14 -0.99 -0.92 -0.62 -0.63 -0.87 -0.81 25.50%
EPS Diluted -1.14 -0.99 -0.92 -0.62 -0.63 -0.87 -0.81 25.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.